Chronic intrarenal infusion of low-dose angiotensin II in dogs increases arterial pressure without impairment of renal function

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 6, 1997, Pages 439-441

  Stevenson, Kathleen M ^a,b   Fitzgerald, Sharyn M ^a,b   Evans, Roger G ^a,b   Anderson, Warwick P ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

angiotensin II; arterial pressure; conscious dogs; kidney; renal blood flow; sodium excretion

Indexed keywords

ANGIOTENSIN;

ANIMAL EXPERIMENT; ARTICLE; DOG; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

EID: 0030960346     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01219.x     Document Type: Article

References (38)

1. Anderson WP, Johnston CI, Korner PI. Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog. J. Physiol. 1979; 287: 231-45.
2. Selig SE, Anderson WP, Korner PI, Casley DJ. The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 h of renal artery stenosis in conscious dogs. J. Hypertens. 1983; 1: 153-8.
3. Anderson WP, Selig SE, Korner PI. Role of angiotensin II in the hypertension induced by renal artery stenosis. Clinical, Experimental Hypertension: Theory and Practice. 1984; A6: 299-314.
4. Anderson WP, Woods RL. Intrarenal effects of angiotensin II in renal arterial stenosis. Kidney Int. 1987; 31: 157-67.
5. Anderson WP, Ramsey DE, Takata M. Development of hypertension from unilateral renal artery stenosis in conscious dogs. Hypertension 1990; 16: 441-51.
6. Denton KM, Anderson WP. Role of angiotensin II in renal wrap hypertension. Hypertension 1985; 7: 893-8.
7. Anderson WP, Woods RL, Denton KM, Alcorn D. Renal actions of angiotensin II in renovascular hypertension. Can. J. Physiol. Pharmacol. 1987; 65: 1559-65.
8. Bagby SP, McDonald WJ, Strong SW, Porter GA, Bennett WM, Bonchek LI. Abnormalities or renal perfusion and the renal pressor system in dogs with chronic aortic coarctation. Circ. Res. 1975; 37: 615-20.
9. Whitlow PL, Katholi RE. Neurohumoral mechanisms in acute aortic coarctation in conscious and anaesthetized dogs. Am. J. Physiol. 1983; 244: H614-21.
10. Reinhart GA, Lohmeier TE, Hord CE Jr. Hypertension induced by chronic renal adrenergic stimulation is angiotensin dependent. Hypertension 1995; 25: 940-9.
11. Parker FB Jr, Farrell B, Streeten DHP, Blackman MS, Sondheimer, HM, Anderson GH Jr. Hypertensive mechanisms in coarctation of the aorta. J. Thorac. Cardiovasc. Surg. 1980; 80: 568-73.
12. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N. Engl. J. Med. 1983; 308: 373-6.
13. Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril. Am. J. Med. 1984; 76: 29-37.
14. Admiraal PJJ, Danser AHJ, Jong MS, Pieterman H, Derkx FHM, Schalekamp MADH. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993; 21: 173-84.
15. Fitzgerald SM, Stevenson KM, Evans RG, Anderson WP. Low dose angiotensin II infusions into the renal artery induce chronic hypertension in conscious dogs. Blood Pressure 1997; 6: 52-61.
16. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells mitogenic responses to angiotensin II. Circ. Res. 1992; 71: 1143-52.
17. Johnson RJ, Alpers CE, Yoshimura A et al. Renal injury from angiotensin II-mediated hypertension. Hypertension 1992; 19: 464-74.
18. Kim S, Ohta K, Hamaguchi A et al. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994; 24: 195-204.
19. Ardaillou R, Sraer J, Chansel D, Ardaillou N, Sraer JD. The effects of angiotensin II on isolated glomeruli and cultured glomerular cells. Kidney Int. Suppl. 1987; 20: S74-80.
20. Anderson WP, Do YS, Hsueh WA. Angiotensin II causes mesangial cell hypertrophy. Hypertension 1993; 21: 29-35.
21. Blantz RC, Konnen KS, Tucker BJ. Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J. Clin. Invest. 1976; 57: 419-34.
22. National Health and Medical Research Council. Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Canberra, Australian Government Publishing Service, 1990.
23. 2-adrenoceptors. Br. J. Pharmacol. 1995; 116: 1557-70.
24. Evans RG, Rankin AJ, Anderson WP. Interactions of blockade of nitric oxide synthase and angiotensin converting enzyme on renal function in conscious rabbits. J. Cardiovasc. Pharmacol. 1994; 24: 542-51.
25. Wilkinson L. SYSTAT: The System for Statistics. Evanston, IL: SYSTAT Inc. 1990.
26. McCubbin JW, DeMoura RS, Page IH, Olmsted F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science 1965; 149: 1394-5.
27. Cowley AW Jr, McCaa RE. Acute and chronic dose-response relationships for angiotensin, aldosterone, and arterial pressure at varying levels of sodium intake. Circ. Res. 1976; 39: 789-97.
28. Dickinson CJ, Yu R. Mechanisms involved in the progressive pressor response to very small amounts of angiotensin in conscious rabbits. Circ. Res. 1967; 20 & 21 (Suppl 2): II-157-63.
29. Lohmeier TE, Cowley AW Jr. Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog. Circ. Res. 1979; 44: 154-60.
30. Hall JE, Guyton AC, Salgado HC, McCaa RE, Balfe JW. Renal hemodynamics in acute and chronic angiotensin II hypertension. Am. J. Physiol. 1978; 253: F174-9.
31. Fisher NDL, Allan D, Kifor I et al. Responses to converting enzyme and renin inhibition: Role of angiotensin II in humans. Hypertension 1994; 23: 44-51.
32. Bellucci A, Wilkes BM. Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. J. Clin. Invest 1984; 74: 1593-600.
33. Wilkes BM, Pion I, Sollott S, Michaels S, Kiesel G. Intrarenal renin-angiotensin system modulates glomerular angiotensin receptors in the rat. Am. J. Physiol. 1988; 254: F345-50.
34. Catt KJ. Angiotensin II receptors. In: Robertson JIS, Nicholls MG (eds). The Renin-Angiotensin System. Gower Medical Publishing, London. 1993; Ch. 12.
35. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am. J. Physiol 1983; 244: F526-34.
36. Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 1981; 35: 265-76.
37. Dzau VJ. Short- and long-term determinants of cardiovascular function and therapy: Contributions of circulating and tissue renin-angiotensin systems J. Cardiovasc. Pharmacol. 1989; 14 (Suppl. 4): S1-5.
38. Anderson WP. Is hypertrophy of the walls of pre-glomerular vessels responsible for hypertension in spontaneously hypertensive rats? Blood Pressure Suppl. 1994; 5: 57-60.